When Fear Spikes, These 5 Quiet, Overlooked Stocks Keep Delivering

The CBOE Volatility Index (VIX) hit 31.77 as of March 9, 2026, up 83.0% from a month ago and sitting in the 98th percentile of readings over the past year. Meanwhile, the S&P 500 is down 1.5% year-to-date, and consumer sentiment registered 56.4 in January 2026, below the recessionary threshold of 60. When fear spikes, most investors flee to gold or Treasuries. But five quietly resilient stocks have been doing the work all along, and most investors aren’t paying attention.

The ranking below weighs dividend stability, earnings consistency, balance sheet strength, and cash flow predictability in a turbulent environment. Boring, by design.

Fluor (NYSE: FLR) carries real near-term baggage, but its recovery thesis is credible. The stock is up 23.24% over the past year and 13.75% year-to-date, though a 13.82% drop last week reflects the market digesting a rough Q4. A $2 billion NuScale write-down drove a net loss of $1.574 billion and full-year operating cash flow of −$387 million. What keeps it on this list: $1.35 billion received from NuScale monetization in Q1 2026, a $1.4 billion share repurchase program, and 2026 adjusted EBITDA guidance of $525 million to $585 million. Fluor’s predominantly reimbursable contract structure limits downside on future projects, and its exposure to infrastructure and energy reshoring makes it a sleeper in a capital-spending recovery.

Interactive Brokers Group (NASDAQ: IBKR) is the contrarian entry here. It’s a brokerage, which doesn’t scream “safe haven.” Yet its model thrives in exactly this environment. Volatility drives trading volume; higher rates boost net interest income. In Q4 2025, commission revenue rose 22% and net interest income rose 20% year-over-year, with a pretax profit margin of 79%. Customer accounts grew 32% to 4.40 million and client equity reached $779.9 billion. The stock is up 40.64% over one year, though a 10.58% pullback over the past month represents a notable pullback from recent highs. Beta sits at 1.251, so it’s not low-volatility, but its structural advantage in choppy markets earns it a place here.

Medtronic (NYSE: MDT) is the classic defensive healthcare play. Though the stock is down 2.39% year-over-year and 5.37% lower year-to-date, this is the most subdued performer on this list. But that’s not the point. In its most recent quarter, revenue grew 8.74% year-over-year to $9.017 billion, with cardiovascular up 13.8% and diabetes up 14.8%. Beta is just 0.729. The dividend tells the real story: Medtronic has paid and grown its quarterly dividend without interruption for 25+ years, with the current quarterly payment at $0.71 per share. Analysts carry a consensus target of $111.69 against a current price near $90.90. The combination of low beta, consistent dividend growth, and steady revenue makes it a frequently cited name in defensive market discussions.

Fortis (NYSE: FTS) is the quietest compounder on the list. The Canadian regulated utility operates across five Canadian provinces, 10 U.S. states, and the Caribbean, with $75 billion in total assets. Its beta of 0.443 is among the lowest in the market. Last week, when the S&P 500 fell nearly 2%, Fortis gained 0.49%. It’s up 30.46% over one year and 10.94% year-to-date. The dividend record is exceptional, with a streak of more than 50 years of annual increases. The most recent quarterly dividend was $0.469 per share (ex-dividend February 17, 2026), with a current dividend yield of 4.34%. In a market this anxious, Fortis holds its ground.

Ameren (NYSE: AEE) is the top-ranked safe haven here, and the price action backs it up. While the broader market has retreated, Ameren is up 6.12% over the past month alone, 11.68% year-to-date, and 14.80% over the past year. The Missouri and Illinois regulated utility posted full-year 2025 operating cash flow of $3.353 billion and guided for 2026 EPS of $5.25 to $5.45, with a long-term target of 6% to 8% EPS CAGR through 2030 backed by a $31.8 billion infrastructure investment plan. The quarterly dividend has grown from $0.55 in 2021 to $0.71 in 2025, with no interruptions. Beta is just 0.531. An additional tailwind is the growing demand for grid expansion from AI data centers, which gives Ameren a long-term growth story typically associated with technology companies.

When the VIX climbs, consumer confidence crumbles, and markets price in elevated risk, the stocks that hold their value rarely dominate financial media. This list spans regulated utilities, a medical device stalwart, a volatility-benefiting brokerage, and an infrastructure giant in recovery mode. Each has a different mechanism for weathering uncertainty, but all share one trait: they keep doing their job regardless of the headlines.